Loading...
Liver-Targeting Class I Selective Histone Deacetylase Inhibitors Potently Suppress Hepatocellular Tumor Growth as Standalone Agents
SIMPLE SUMMARY: Liver cancers are among the leading causes of global cancer deaths. The current therapy options for liver cancers, including hepatocellular carcinoma (HCC), which accounts for over 80% of all cases, have afforded limited benefit to patients with an advanced disease state. HCC results...
Na minha lista:
| Udgivet i: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7690782/ https://ncbi.nlm.nih.gov/pubmed/33114147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12113095 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|